Clinical trial
Local Consolidative Therapy (LCT) in Patients With Advanced Stage Non-small Cell Lung Cancer Who do Not Progress After Front Line Systemic Therapy
NCT03046316 is registered in ClinicalTrials.gov with Guangdong Association of Clinical Trials as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Local Consolidative Therapy (LCT) in Patients With Advanced Stage Non-small Cell Lung Cancer Who do Not Progress After Front Line Systemic Therapy
- Lead sponsor
- Guangdong Association of Clinical Trials
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 1, 2020
- Completion date
- July 1, 2026
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.